ArticlePloS one2018

Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation.

Ademuyiwa S Aromolaran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.